Related by context. All words. (Click for frequent words.) 82 RNAi Therapeutic 78 Systemic Delivery 77 Drug Candidate 77 Preclinical Data 77 Novel Therapeutic 77 Therapeutic Antibody 76 Clinical Trial Results 76 Malaria Vaccine 76 Novel Antibiotic 76 Develop Novel 76 Tumor Targeting 76 Therapeutic Vaccines 76 Novel Mechanism 76 Lung Cancer Drug 76 Initiates Clinical Trial 76 Initiates Clinical 76 Phase 2a Trial 75 Cancer Stem Cells 75 Phase 2b Clinical Trial 75 Nicotine Vaccine 75 Anti Tumor 75 Meets Primary Endpoint 75 Novel Oral 75 Vaccine Candidate 75 Files IND 75 Presents Preclinical Data 75 Novel Therapies 75 Small Molecule 75 Epilepsy Drug 75 IND Filing 75 Monoclonal Antibodies 74 TB Vaccine 74 Gout Drug 74 Receives Milestone Payment 74 Present Preclinical Data 74 Therapeutic Targets 74 Kinase Inhibitor 74 Receives Orphan Drug Designation 74 Immunomedics Announces 74 Collaborators Publish 74 Therapeutic Potential 74 Biomarker Study 74 Patent Covering 74 siRNA Delivery 73 Anticancer Drug 73 Therapeutic Antibodies 73 Schizophrenia Drug 73 Phase III Clinical Trial 73 Companion Diagnostic 73 Receives Orphan Drug 73 Patient Enrollment 73 HCV Protease Inhibitor 73 JAK2 Inhibitor 73 Vaccine Adjuvant 73 Completes Patient Enrollment 73 Drug Shows Promise 73 Initiates Phase II 73 Renal Cancer 73 Immunotherapeutic 73 Investigational Treatment 73 Prolongs Survival 73 Shows Promise Against 73 Cancer Therapies 73 Psoriasis Drug 73 Tyrosine Kinase Inhibitor 73 Patent Broadly Covering 73 Viral Infections 73 Successfully Completes Phase 73 Presents Positive 72 BiTE Antibody 72 Recombinant Protein 72 Novel Vaccine 72 Anti Angiogenesis 72 Lupus Drug 72 Rheumatoid Arthritis Drug 72 Oral Fingolimod 72 Commercialize Novel 72 Investigational Compound 72 Phase IIb Clinical Trial 72 Anti Tumor Activity 72 JAK Inhibitor 72 Shows Promising 72 AVI BioPharma Announces 72 Inflammatory Arthritis 72 Protein Involved 72 HDAC Inhibitor 72 Clinical Outcome 72 Initiates Phase III 72 Inflammatory Diseases 72 Arthritis Drug 72 Demonstrates Positive 72 Prostate Cancer Vaccine 72 Avian Flu Vaccine 72 Combination Treatment 72 Personalised Medicine 72 Investigational Agent 72 Drug Combo 72 Monoclonal Antibody 72 Hepatitis C Treatment 72 Immune Cell 72 Investigational Drug 72 Phase III Trial 72 Autoimmune Diseases 71 Oral Calcitonin 71 Protein Therapeutics 71 Hedgehog Pathway 71 Hsp# Inhibitor 71 Earns Milestone Payment 71 Pulmonary Arterial Hypertension 71 Initiates Enrollment 71 Cancer Immunotherapy 71 Kinase Inhibitors 71 Hematological Cancers 71 Sangamo BioSciences Announces 71 Collaborators Present 71 Demonstrates Efficacy 71 Anticancer Activity 71 Cancer Vaccines 71 Therapeutic Vaccine 71 Stem Cell Treatment 71 Metabolic Disorder 71 Transdermal Patch 71 Liver Toxicity 71 Drug Resistant 71 Hematological Malignancies 71 Phase 2b Trial 71 Patents Covering 71 Osteoporosis Drug 71 Improves Survival 71 Small Molecules 71 First Patient Enrolled 71 Milestone Payment 71 Genetic Variation 71 Demonstrates Ability 71 Chemotherapeutic Agents 71 FDA Accepts 71 Migraine Drug 71 Advanced Melanoma 71 Shows Efficacy 71 Human Monoclonal Antibodies 71 Awarded Qualifying Therapeutic 71 Synthetic Peptide 71 Inflammatory Disease 71 Submits NDA 71 Tuberculosis Vaccine 71 Phase 1b Clinical Trial 71 Genes Involved 71 Phase 2a Clinical Trial 70 Rotavirus Vaccine 70 Multiple Myeloma Patients 70 Protein Linked 70 Reports Preclinical Data 70 Fungal Infections 70 Mouse Model 70 Anti Angiogenic 70 Molecular Diagnostic 70 Angiogenic 70 Pooled Analysis 70 Biopharmaceutical Industry 70 Insulin Resistance 70 Smallpox Vaccine 70 Antiviral Drugs 70 Ebola Vaccine 70 Anticancer Agent 70 NDA Submission 70 Immune Cells 70 Smooth Muscle 70 Topical Treatment 70 Tumor Suppressor 70 Initiate Phase III 70 Renal Cell Carcinoma 70 Completes Enrollment 70 Regenerative Cells 70 Targeted Therapies 70 Initiates Dosing 70 Vaccine Adjuvants 70 Antitumor Activity 70 Novel Approaches 70 Novel Treatments 70 Treatment Reduces 70 Antisense Drug 70 Demonstrates Significant 70 Signaling Pathway 70 Protease Inhibitor 70 Blood Pressure Drug 70 Receive Milestone Payment 70 Announces Poster Presentations 70 Male Contraceptive 70 rxRNA 70 FDA Okays 70 Nasal Powder 70 Novel Therapeutics 70 Seasonal Influenza Vaccine 70 Aurora Kinase 70 IND Application 70 Dendritic Cells 70 Drug Prevents 70 Autoimmune Disease 70 Rheumatoid Arthritis Patients 70 Metabolic Disease 70 Romidepsin 70 Protein Biomarker 70 Cetrorelix 70 Protein Expression 70 Artificial Pancreas 70 Therapeutic Competitors Companies 70 Shown Effective 70 Develops Novel 70 Treating Chronic 70 Combo Therapy 70 Mimetics 70 Pandemic Influenza Vaccines 70 Preclinical Study 70 Flamel Technologies Announces 69 Severe Sepsis 69 Antibody Discovery 69 Trial Evaluating 69 First Patient Dosed 69 Cholesterol Drug 69 Key Milestones 69 Aptamer 69 Combination Therapy 69 Combination REOLYSIN R 69 Myelodysplastic Syndromes 69 Novel Antibody 69 Drug Fails 69 Granted Orphan Drug 69 Hepatocellular Carcinoma 69 Therapeutic Efficacy 69 Preclinical Efficacy 69 Cancer Treatments 69 Anti Inflammatory Drug 69 Demonstrates Sustained 69 Gene Silencing 69 Novel Protein 69 Breast Cancer Metastasis 69 Phase III Trials 69 Myeloma Patients 69 Study Evaluating 69 RNA Interference 69 Effectively Treats 69 Initiate Clinical Trial 69 microRNA Therapeutics 69 Antiviral Activity 69 Gene Variants 69 Tumor Growth 69 Ozarelix 69 Abstract Accepted 69 Vaccine Protects Against 69 Pafuramidine 69 Nerve Regeneration 69 Antibody Drug Conjugate 69 Cholesterol Lowering Drug 69 Novel Compound 69 Molecular Diagnostic Test 69 Nanoemulsion 69 Antigen Specific 69 Licenses Novel 69 Efficacy Trial 69 Preclinical Models 69 Phase IIb Trial 69 Autoimmune Disorders 69 Experimental Vaccine 69 Osteoporosis Treatment 69 Proves Effective 69 Single Dose 69 Transdermal Delivery 69 Previously Treated 69 Toxicogenomics 69 Treatment Regimen 69 Minimally Invasive Treatment 69 Demonstrates Potential 69 Protein Synthesis 69 Hepatitis C Virus 69 Ridaforolimus 69 Cervical Cancer Vaccine 69 Gene Mutation 69 Treatment Naïve 69 Hepatitis C Infection 69 Anti Clotting Drug 69 Mouse Models 69 Neural Stem Cells 69 Signaling Pathways 69 Phase IIa Clinical Trial 69 Inflammatory Markers 69 Cancer Vaccine 69 Confirms Efficacy 69 Diagnostic Tests 69 Recombinant Human 69 Poster Presentations 69 platform HDL Mimetic 69 Helps Predict 68 Significantly Improved 68 Survival Benefit 68 Mylan Receives Approval 68 Cell Adhesion 68 Diabetic Foot Ulcer 68 Blood Cancers 68 Pivotal Phase III 68 Liposomal 68 Biologics Manufacturing 68 Patients Receiving 68 Dose Escalation 68 HIV Integrase 68 Factor Receptor 68 See CLINICAL PHARMACOLOGY 68 Neoadjuvant Chemotherapy 68 Novel Anticancer 68 Clinical Trial Evaluating 68 Submits Biologics License Application 68 First Patient Treated 68 FOLOTYN ® 68 Skeletal Muscle 68 BioSante Pharmaceuticals Announces 68 Gene Variant 68 Begins Dosing 68 Whole Genome Sequencing 68 Acute Heart Failure 68 Significantly Improves 68 Genetic Mutation 68 Randomized Clinical Trials 68 Universal Flu Vaccine 68 Oligonucleotides 68 Gene Variation 68 Phase III Pivotal 68 ALN TTR 68 Sapacitabine 68 Schizophrenia Treatment 68 Virus Infection 68 Genetic Disorder 68 DNA Methylation 68 Novel Compounds 68 Leukemia Cells 68 Blood Thinner 68 Achieves Primary Endpoint 68 Blood Clotting 68 pralatrexate injection folate analogue 68 Oligonucleotide 68 FDA Approvals 68 Cell Transplant 68 Lung Cancer Survival 68 Initiate Phase 68 Gene Linked 68 Preclinical Development 68 Phase 2b Study 68 Cell Differentiation 68 Treatment Shows Promise 68 Potent Antiviral Activity 68 Pharmacyclics Announces 68 Epidermal Growth Factor Receptor 68 Nuvelo Announces 68 Toxicity Testing 68 Prostate Cancer Patients 68 Genetic Testing 68 Idenix Novartis 68 Gastrointestinal Disorders 68 Influenza Vaccine Production 68 Metastatic Melanoma 68 Receptor Agonist 68 Interferon Gamma 68 Enlarged Prostate 68 Transdermal Drug 68 Teva Provides Update 68 Demonstrates Potent 68 Hospital Acquired Pneumonia 68 Begin Clinical Trials 68 Treat Heart Failure 68 Anticancer Drugs 68 Pharmacokinetic Study 68 Tezampanel 68 Well Tolerated 68 Generic Version 68 Personalized Immunotherapy 68 Anticancer Compound 68 Genes Linked 68 Endothelial Cells 68 Thyroid Hormone 68 Improves Outcomes 68 Pivotal Study 68 Prostate Cancer Treatment 68 Oral Mucositis 68 Fast Track Status 68 Shows Promise 68 Patients Treated With 68 Protein Interactions 68 Study Demonstrates 68 Targeted Therapy 68 Atopic Dermatitis 68 Oral Presentations 68 Orally Active 68 Postdoctoral Position 68 Antifungal 68 Clinical Trial Data 68 Genes Predict 68 Innate Immune 67 Lupus Nephritis 67 Potentially Fatal 67 Inhaled Liposomal Ciprofloxacin 67 Breast Cancer Cells 67 Protein Interaction 67 Early Diagnosis 67 Preclinical Evaluation 67 Pivotal Phase 67 Test Detects 67 Neural Stem Cell 67 Laryngeal Cancer 67 Pathogen Detection 67 Genetic Variant 67 Genetic Variations 67 Pivotal Trial 67 Data Suggest 67 Immune Mediated 67 Anthrax Vaccine 67 Antipsychotic Drug 67 Chronic Myeloid Leukemia 67 Inhibits 67 Presents Preclinical 67 Newly Identified 67 AnaSpec Introduces 67 Histone Deacetylase 67 Stapled Peptide 67 Circulating Tumor Cells 67 Accelerate Commercialization 67 Erectile Dysfunction Drug 67 Molecular Mechanism 67 Maven Semantic 67 Clinical Trial Enrollment 67 ARRY # 67 Cutaneous T 67 Anemia Drug 67 Lymphoid 67 Brain Tumor Therapy 67 Milestone Payments 67 Adjuvant Treatment 67 Treatment Experienced 67 Gastrointestinal Stromal Tumors 67 Expanded Indication 67 Patient Enrolment 67 Disease Progression 67 Biomarker Discovery 67 Anti CD# Antibody 67 Influenza Vaccine 67 Completes Dosing 67 Tyrosine Kinase Inhibitors 67 GATTEX TM 67 Entry Inhibitor 67 Slow Progression 67 Alnylam Biotherapeutics 67 Stem Cell Transplants 67 Randomized Phase 67 Immune Responses 67 Immunomodulatory 67 Hormone Refractory Prostate Cancer 67 Improve Diagnosis 67 Vascular Targeting Agents 67 Recurrent Breast Cancer 67 Inhaled Insulin 67 Interferon Beta 67 Submits IND 67 Breast Cancer Recurrence 67 KL4 Surfactant 67 Polymerase Inhibitor 67 Antiangiogenic 67 Dose Ranging 67 Cocaine Addiction 67 Long Term Efficacy 67 ALN PCS 67 Osteoporosis Drugs 67 Progenitor Cells 67 Solid Tumor 67 Patent Issued 67 Advanced Ovarian Cancer 67 Brain Plasticity 67 Milestone Payment From 67 Stakeholder Opinions 67 Vicriviroc 67 Lung Cancers 67 Asthma COPD 67 Asthma Treatment 67 Therapeutic Effects 67 Injectable Drug 67 MMR Vaccine 67 Therapy Evaluation 67 Renal Cell Cancer 67 CysDisplay R 67 Study Reinforces 67 Ovarian Cancer Patients 67 Humanized Anti 67 Malignant Glioma 67 Onyx Pharmaceuticals Announces 67 Diamyd Medical Diamyd 67 Cholesterol Drugs 67 Scientists Identify 67 Proven Effective 67 Cell Transplants 67 Novel Method 67 Breast Tumors 67 Gastric Cancer 67 Clinically Significant 67 Treatment Naive Patients 67 Intravenous Formulation 67 Cancer Cells 67 Benign Prostatic Hyperplasia 67 Files Investigational 67 Cell Proliferation 67 Autologous Stem Cell Transplantation 67 Improve Survival 67 Lowers Risk 67 Fabry Disease 67 Cites Positive 67 Inhaled Nitric Oxide 67 Receives Approvable Letter 67 Clostridium difficile Infection 67 Plaque Psoriasis 67 Randomized Trials 67 Relapsing Multiple Sclerosis 67 Initiates Clinical Trials 67 Chronic Hepatitis C 67 Gene Mutations 67 Embryonic Stem Cells 66 Patient Accrual 66 Researchers Identify 66 Dose Ranging Study 66 Safinamide 66 Oral Insulin 66 Brain Cells 66 Fragment Based 66 Lung Cancer Patients 66 Disease Modifying 66 Treating Depression 66 Chronic Hepatitis B 66 Issued Patent 66 Clinical Efficacy 66 Advanced Colorectal Cancer 66 Ion Channels 66 Improve Outcomes 66 Drug Resistant Tuberculosis 66 Announce License Agreement 66 Postmenopausal Osteoporosis 66 Malignancies 66 Trodusquemine MSI 66 Spectrum Pharmaceuticals Announces 66 Solid Tumors 66 Rotavirus Vaccines 66 Cognitive Deficits 66 Million Milestone Payment 66 Synaptic Plasticity 66 Subgroup Analysis 66 Antibody Therapeutics 66 Novel Peptide 66 Osteoarthritis Pain 66 Pandemic Influenza Vaccine 66 Insulin Sensitivity 66 Severe Asthma 66 FDA Clears 66 Exclusive License 66 DOR BioPharma Announces 66 Initiates Phase 2b 66 Phosphorescent OLED Lighting 66 Brentuximab Vedotin SGN 66 Cervical Dysplasia 66 Human Neural Stem 66 Alvine Pharmaceuticals 66 Develop Innovative 66 Complicated Skin 66 Microbicide 66 MEK Inhibitor 66 Nanophase Announces 66 Study Shows Benefits 66 Diabetic Nephropathy 66 Generic Versions 66 SBIR Grant 66 Resistant Hypertension 66 Randomized Double blind 66 Double Blind Placebo 66 Viral Disease 66 Dosage Forms 66 Findings Suggest 66 Mesothelioma Treatment 66 Novel Small Molecule 66 Acne Drug 66 Pharmacogenomic 66 Glaucoma Treatment 66 Muscle Wasting 66 Detect Cancer 66 Vascular Inflammation 66 Secondary Hyperparathyroidism 66 Nerve Cells 66 Genes Identified 66 Newly Diagnosed 66 Antitumor 66 Induces 66 rPA Anthrax Vaccine 66 Meta Analysis 66 Treated Patients 66 Orphan Diseases 66 Multidrug Resistant 66 Adjuvant Chemotherapy 66 Phase Ib Clinical Trial 66 Potent Inhibitor 66 Kidney Transplant Patients 66 Bosutinib 66 Radiation Induced 66 Neuroprotection 66 Inc Therapeutic Competitors 66 Lipid Lowering 66 Locked Nucleic Acid 66 Therapeutic Agents 66 Demonstrated Significant 66 Effective Treatments 66 Initiates Phase 66 Sleep Disturbances 66 Data Indicate 66 Emerging Therapies 66 Novel Inhibitor 66 Companion Diagnostics 66 Advanced Pancreatic Cancer 66 Statin Drugs 66 Advanced Prostate Cancer 66 Submits Response 66 Pulmonary Drug 66 Low Dose 66 Breast Tumor 66 MKC# MKC# PP 66 Alnylam #x# 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 II Clinical Trial 66 Receives Complete Response 66 Telik Announces 66 Cytotoxic 66 Molecular Basis 66 Imaging Techniques 66 Antigens 66 Beneficial Effects 66 Viral Suppression 66 Oncolytic 66 Expand Collaboration 66 Diabetic Neuropathy 66 Molecular Mechanisms 66 Pluripotent Stem Cells 66 Clinical Evaluation 66 Bone Marrow Stem Cells 66 Aganocide 66 Antisense 66 Anti Inflammatory 66 VIVITROL ® 66 Hypercholesterolemia 66 RNA Therapeutics 66 Long Term Survival 66 Bipolar Depression 66 DiLA2 66 Prostate Tumors 66 Multiple Sclerosis Rheumatoid Arthritis 66 Showed Significant 66 IL# PE#QQR 66 Technological Advances 66 Hypertensive Patients 66 TNF Blockers 66 Crit Rev 66 Avian Influenza Vaccine 66 Biosimilar 66 TKB# 66 Receives Fast Track 66 Cardiotoxicity 66 Controlled Study 66 Maribavir 66 Improved Survival 66 Novel Anti Inflammatory 66 Guidelines Recommend 66 Integrase Inhibitor 66 Aztreonam Lysine 66 Placebo Controlled Study 66 HER2 Positive Breast Cancer 66 Bacterial Infections 66 Testosterone Patch 66 Eye Diseases 66 Osteoarthritis Patients 66 Identifies Potential 66 Bladder Cancer 66 Human Antibody 66 PDUFA Date 66 FDA Approves Drug 66 Metastatic Cancer 65 Pivotal Trials 65 Factor Xa Inhibitor 65 Anticancer Agents 65 Predict Risk 65 Breast Cancer Stem Cells 65 Commences Phase 65 Drug Formulation 65 Antifungals 65 Drug Pipeline 65 ADHD Medication 65 Ecallantide 65 Therapy Improves 65 Study Evaluates 65 Paliperidone Palmitate 65 Stomach Cancer 65 RNA Interference RNAi 65 Lung Cancer Trial 65 Muscle Function 65 Appears Safe 65 Cognitive Problems 65 Preterm Labor 65 Microfluidic Devices 65 Gene Expression Analysis 65 Genetic Markers 65 Anthrax Toxin 65 Fewer Side Effects 65 Retroviral 65 Romiplostim 65 Enzyme Replacement Therapy 65 Immunostimulatory 65 Antimalarial 65 Commercialize 65 Clinical Validation 65 Diabetic Patients 65 Anthracycline 65 TRANSDUR ™ 65 Vitro Activity 65 Adenoma 65 Infected Patients 65 Allergic Rhinitis 65 Migraine Treatment 65 Breast Cancer Treatment 65 Presents Positive Preclinical 65 Carotid Stenting 65 candidates Azedra 65 Successfully Treated 65 Heart Stents 65 Noninvasive Prenatal 65 TNF Alpha 65 Stent Coating 65 Prophylactic Treatment 65 ALN HPN 65 Patients Suffering 65 NMDA Receptor 65 Antibiotic Resistant 65 Bone Marrow Cells 65 Metastatic Renal Cell Carcinoma 65 Agonist MABA program 65 Dry Powder Inhalers 65 Receives CE Marking 65 oncolytic virus therapies 65 Relapsed Multiple Myeloma 65 Vaccine Prevents 65 Neuroendocrine Tumors 65 Brain Tumors 65 Innate Immunity 65 Bucindolol 65 Internationally Recognized 65 Tumor Necrosis Factor 65 Therapeutic Monoclonal Antibodies 65 Aliskiren 65 Mucosal 65 Pivotal Clinical Trial 65 Pandemic Flu Vaccine 65 Aggressive Prostate Cancer 65 Glufosfamide 65 Reduces Risk 65 Patient Dosing 65 Beta Blocker 65 Hematological 65 Poniard Pharmaceuticals Announces 65 Antiviral Drug 65 Pediatric Patients 65 Mammalian Cell Culture 65 Metabolomics 65 Acute Ischemic Stroke 65 Allosteric 65 Analytical Tool 65 cMET 65 Islet Transplantation 65 Blood Thinning 65 Adjuvanted 65 Elagolix 65 Reduced Risk 65 Announces Initiation 65 Suppresses 65 Blinatumomab 65 Unfractionated Heparin 65 Protein Biomarkers 65 novel VDA molecule 65 Visceral Fat 65 Growth Hormone Deficiency 65 Less Invasive 65 Multipotent 65 Oral Laquinimod 65 Cardiomyocytes 65 Chemotherapy Regimen 65 Pivotal Phase II 65 Oral Formulation 65 Fondaparinux 65 Disease IBD 65 Receptor Antagonist 65 Serious Infections 65 Files Patent Application 65 Plasmid DNA 65 Biomarker 65 Estrogen Therapy 65 Aethlon Medical Announces 65 Scaffold Based 65 Treating Heart Failure 65 Ocular Disease 65 investigational humanized monoclonal antibody 65 Sipuleucel T 65 Chronic Inflammation 65 Inhaled Corticosteroids 65 Achieves Milestone 65 Vaccine Shows Promise 65 Phase III Clinical Trials 65 Imaging Technique 65 Cannabinoid 65 Metastatic Colorectal Cancer 65 Heartburn Drugs 65 Induced Pluripotent Stem Cells 65 Further Validates 65 Stem Cell Breakthrough 65 StaphVAX R 65 SIX RO ROG 65 Xcytrin R 65 Study Indicates 65 oral prodrug 65 Aethlon Medical Releases 65 Taxane 65 motexafin gadolinium Injection 65 Stem Cell Therapies 65 Receives Patent 65 Completes Patient Enrolment 65 Nucleic Acid 65 Newly Diagnosed Patients 65 Skin Disorders 65 AAG geldanamycin analog 65 Invasive Breast Cancer 65 Valortim TM 65 Contrast Agent 65 Patients Enrolled 65 Small Molecule Drug 65 Bird Flu Vaccine 65 Genetic Susceptibility 65 Eradicates 65 Image Guided 65 Renin Inhibitor 65 Provides Detailed 65 Nasdaq Deficiency Notice 65 Sustained Reduction 65 Announces Presentation 65 HuCAL PLATINUM R 65 Synta Announces 65 C1 Inhibitor 65 LibiGel ® 65 Sustained Efficacy 65 Bone Metastases 65 Intravenous Immunoglobulin 65 Issues Shareholder 65 Multicenter Randomized 65 Holds Promise 65 Molecular Pathogenesis 65 Brain Metastases 65 Lung Cancer Vaccine 65 Bone Marrow Transplants 65 Announces FDA Clearance 65 Lung Cancer Treatment 64 Malignant Melanoma 64 Male Infertility 64 Neurodegenerative Disease 64 Dengue Virus 64 Non Invasive Treatment 64 CYT# potent vascular disrupting 64 Progressive Multifocal Leukoencephalopathy 64 Live Attenuated 64 CD# CEA 64 Urinary Incontinence 64 Antipsychotic Drugs 64 Hepatic Encephalopathy 64 Analytical Method 64 Relapsed Refractory 64 Deforolimus 64 Therapy Reduces 64 Genotyping Test 64 BioElectronics Announces 64 Antipsychotic Medications 64 Gets FDA Clearance 64 Statin Therapy 64 Pirfenidone 64 Upcoming Milestones 64 Tumor Microenvironment 64 Stem Cell Procedure 64 Increased Mortality 64 Tumor Targeted 64 Diabetic Kidney Disease 64 GRAS Status 64 Morpholino 64 Guidelines Issued 64 Critically Ill Patients 64 Confirmatory Phase 64 Breast Cancer Patients 64 Platelet Inhibition 64 Wound Dressings 64 Derma Sciences Announces 64 Subtypes 64 Cytotoxicity 64 Genetic Disorders 64 Rigel R# 64 Patient Outcomes 64 Assay Kits 64 Doripenem 64 Phenotypes 64 Overactive Bladder 64 Treating Prostate Cancer 64 Epithelial 64 Demonstrates Statistically Significant 64 Anti Infectives 64 Protein Structures 64 Preclinical Testing 64 product platforms AZX# 64 Transcription Factor 64 Nymox NX 64 Helps Identify 64 Vulnerable Plaque 64 ISTODAX ® 64 PKC# 64 Shingles Vaccine 64 Nerve Cell 64 CCX# B 64 Investigator Initiated 64 Localized Prostate Cancer 64 Announce Collaboration Agreement 64 Gentium Announces 64 Dalbavancin 64 Cholesterol Lowering 64 acetonide FA 64 Pre Cancerous 64 Sustained Release 64 Shows Statistically Significant 64 Study Identifies 64 Influenza Virus 64 Liver Injury 64 Antidepressant Drug 64 Issues Surrounding 64 Atypical Antipsychotic 64 Advanced Renal Cell 64 Gene Therapy Trial 64 Protein Protein Interaction 64 Adjuvant Therapy 64 VIVUS Announces 64 Virus Linked 64 Stem Cell Transplant 64 Bazedoxifene 64 Gene Expression Profiling 64 Nicotine Addiction 64 Tissue Repair 64 MKC# MT 64 Drug Repositioning 64 Statistically Significant 64 Therapeutic Protein 64 Cancer Therapeutic 64 Risk Stratification 64 Venous Thromboembolism 64 iPS Cells 64 PRN FDA Approves 64 PharmaVitae Profile 64 Study Showed 64 Structure Function 64 Denufosol 64 Enrolling Patients 64 Colorectal Cancer Patients 64 Arthritis Drugs 64 Polymer Material 64 Ophthalmic Drug 64 Conjugate 64 Menopausal Women 64 EVIZON TM 64 Ovarian Cancer Treatment 64 Modulates 64 Hematopoietic Stem Cell Transplantation 64 Heart Failure Patients 64 candidates Azedra TM 64 Randomized Double Blind Placebo 64 Glucocorticoid 64 Chronic Lymphocytic Leukemia 64 Hedgehog Pathway Inhibitor 64 Adult Stem Cell Therapy 64 Progenitor Cell 64 Hepatitis B Virus 64 Genetic Tests 64 Anti Infective 64 Antibiotic Resistance 64 Bavituximab 64 Study Validates 64 Refractory Hodgkin Lymphoma 64 Artificial Liver 64 Electroporation 64 Soft Tissue Sarcoma 64 Significant Improvements 64 Genes Associated 64 Peripheral Blood 64 Attenuates 64 Oxidative Stress